Jason Gotlib

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 27 papers. Top paper: “Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial”.

Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial

Nature Medicine(2021)10.1038/s41591-021-01539-8

N/A

4.0DataRank · unranked

147 citations

Andreas Reiter, Deepti Radia, Michael W. Deininger, Tracy I. George, Jens Panse +19 more

Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts

Theranostics(2020)10.7150/thno.46719

N/A

0.782DataRank · unranked

183 citations

Cem Akin, Karin Hartmann, Gunnar Nilsson, Andreas Reiter, Olivier Hermine +20 more

Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial

Nature Medicine(2021)10.1038/s41591-021-01538-9

N/A

0.753DataRank · unranked

150 citations

Deepti Radia, Tracy I. George, William A. Robinson, Albert Quiery, Mark W. Drummond +13 more

Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.03.007

N/A

0.639DataRank · unranked

70 citations

Karin Hartmann, Juliana Schwaab, Iván Álvarez‐Twöse, Knut Brockow, Patrizia Bonadonna +22 more

Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.03.001

N/A

0.593DataRank · unranked

51 citations

Karl Sotlar, Mohamad Jawhar, Thomas Kielsgaard Kristensen, Guillaume Bachelot, Bogusław Nedoszytko +22 more

Tuning MPL signaling to influence hematopoietic stem cell differentiation and inhibit essential thrombocythemia progenitors

Proceedings of the National Academy of Sciences(2020)10.1073/pnas.2017849118

N/A

0.533DataRank · unranked

34 citations

Ignacio Moraga, Tristan Lerbs, Camille Van Neste, Stephan Wilmes, Naotaka Tsutsumi +12 more

Comparison of the Transcriptomic Signatures in Pediatric and Adult CML

Cancers(2021)10.3390/cancers13246263

N/A

0.470DataRank · unranked

22 citations

Stephanie M. Smith, Alex Gia Lee, Hee‐Don Chae, Elizabeth Spiteri, Jason Erdmann +24 more

Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference

Journal of Allergy and Clinical Immunology(2021)10.1016/j.jaci.2021.03.008

N/A

0.406DataRank · unranked

14 citations

Tracy I. George, Melody C. Carter, K. Frank Austen, Bruce S. Bochner, Daniel F. Dwyer +24 more

Long-term survival can be achieved in a significant fraction of older patients with core binding factor acute myeloid leukemia treated with intensive chemotherapy

Haematologica(2024)10.3324/haematol.2024.285448

N/A

0.241DataRank · unranked

4 citations

Erika Borlenghi, Mark R. Litzow, John C. Byrd, Cristina Papayannidis, Cristina Tecchio +34 more

Tuning TPO-R signaling to influence hematopoietic stem cell differentiation and inhibit essential thrombocythemia

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.23.290593

N/A

0.165DataRank · unranked

2 citations

Ignacio Moraga, Tristan Lerbs, Camille Van Neste, Stephan Wilmes, Naotaka Tsutsumi +12 more

The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT

The Journal of Allergy and Clinical Immunology In Practice(2023)10.1016/j.jaip.2023.08.008

N/A

0DataRank · unranked

47 citations

Gregor Hoermann, Patrizia Bonadonna, Karin Hartmann, Wolfgang R. Sperr, Sigurd Broesby‐Olsen +27 more

Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial

Haematologica(2023)10.3324/haematol.2022.282411

N/A

0DataRank · unranked

17 citations

Lynda Foltz, Vikas Gupta, Robert P. Hasserjian, Taghi Manshouri, John Mascarenhas +15 more

Enkurin: a novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens

Blood Advances(2023)10.1182/bloodadvances.2022008939

N/A

0DataRank · unranked

6 citations

Yi Liu, Jason Wu, Lenn Fechter, Kanagavel Murugesan, Holden T. Maecker +5 more

Enkurin: A novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.07.523111

N/A

0DataRank · unranked

0 citations

Yi Liu, Jason Wu, Lenn Fechter, Kanagavel Murugesan, Holden T. Maecker +5 more

Harmonization of Diagnostic Criteria in Mastocytosis for Use in Clinical Practice: WHO vs ICC vs AIM/ECNM

The Journal of Allergy and Clinical Immunology In Practice(2024)10.1016/j.jaip.2024.08.044

N/A

0DataRank · unranked

33 citations

Karin Hartmann, Gregor Hoermann, Andreas Reiter, Iván Álvarez‐Twöse, Knut Brockow +24 more

Proposals for revised International Working Group–European LeukemiaNet criteria for anemia response in myelofibrosis

Blood(2024)10.1182/blood.2024025802

N/A

0DataRank · unranked

25 citations

Giovanni Barosi, Francesco Passamonti, Juan Carlos Hernández‐Boluda, Prithviraj Bose, Konstanze Döhner +33 more

Evolution of mast cell research associated with the Laboratory of Allergic Diseases, 1985-2022: Summary of the 2023 NIAID Symposium

Journal of Allergy and Clinical Immunology(2025)10.1016/j.jaci.2025.06.029

N/A

0DataRank · unranked

1 citations

Gunnar Nilsson, Yoshimichi Okayama, Yoseph A. Mekori, Ana Olivera, Peter Valent +12 more

Correlates of organ damage in patients with advanced systemic mastocytosis enrolled in clinical trials of avapritinib

Blood Neoplasia(2025)10.1016/j.bneo.2025.100127

N/A

0DataRank · unranked

0 citations

Cecelia Perkins, Rong Lü, Hongliang Shi, Saša Dimitrijević, Justin Abuel +6 more

Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review

The Journal of Allergy and Clinical Immunology In Practice(2021)10.1016/j.jaip.2021.06.011

N/A

0DataRank · unranked

82 citations

Cem Akin, Patrizia Bonadonna, Frank Siebenhaar, Sigurd Broesby‐Olsen, Knut Brockow +27 more

Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasms

Cell Reports Medicine(2021)10.1016/j.xcrm.2021.100425

N/A

0DataRank · unranked

56 citations

Wenfei Du, Cecelia Perkins, Lenn Fechter, Vanita Natu, Holden T. Maecker +5 more

COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)

The Journal of Allergy and Clinical Immunology In Practice(2021)10.1016/j.jaip.2021.03.041

N/A

0DataRank · unranked

41 citations

Knut Brockow, Marek Niedoszytko, Hanneke Oude Elberink, Cem Akin, Bogusław Nedoszytko +28 more

A novel activating JAK1 mutation in chronic eosinophilic leukemia

Blood Advances(2021)10.1182/bloodadvances.2021004237

N/A

0DataRank · unranked

21 citations

Alisa Damnernsawad, Talent Theparee, David A. Sampson, Quinlan Morrow, Fei Yang +6 more

Platelet Transcriptome Yields Progressive Markers in Chronic Myeloproliferative Neoplasms and Identifies Putative Targets of Therapy

Blood(2021)10.1182/blood-2021-153323

N/A

0DataRank · unranked

1 citations

Wenfei Du, Cecelia Perkins, Lenn Fechter, Vanita Natu, Holden T. Maecker +5 more

Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes

Allergy(2022)10.1111/all.15544

N/A

0DataRank · unranked

161 citations

Amy D. Klion, Florence Roufosse, Dagmar Simon, Georgia Metzgeroth, Kristin M. Leiferman +18 more

Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.05.007

N/A

0DataRank · unranked

89 citations

Karin Hartmann, Patrizia Bonadonna, Theo Gülen, Knut Brockow, Iván Álvarez‐Twöse +27 more

Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.05.036

N/A

0DataRank · unranked

27 citations

Tracy I. George, Philip M. Kluin, Andreas Reiter, Juliana Schwaab, Jens Panse +23 more

Proposed European Competence Network on Mastocytosis—American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis

The Journal of Allergy and Clinical Immunology In Practice(2022)10.1016/j.jaip.2022.05.034

N/A

0DataRank · unranked

21 citations

Juliana Schwaab, William Shomali, Tracy I. George, Deepti Radia, Mariana Castells +27 more